About Riddhima Chakraborty
Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries.
Recent Articles By Riddhima Chakraborty
Beware of These 4 Overvalued Large-Cap Stocks
Despite the latest federal interest rate increases, the U.S. markets are plumbing record lows amid skyrocketing core inflation. Given the volatile backdrop, we think it could be wise to avoid the stocks of large-cap companies Clorox Company (CLX), Consolidated Edison (ED), Telefónica (TEF), and Avis Budget Group (CAR). These stocks look overvalued at their current price levels and might witness further declines in the near term. Let’s discuss.
3 Stocks Wall Street Believes Are Headed Lower
Given the current, bearish market owing to federal interest rate hikes, a prospective recession, and historically high inflation, Wall Street analysts believe the stocks of fundamentally weak companies J. M. Smucker (SJM), Kimberly-Clark (KMB), and Annaly Capital Management (NLY) are heading lower in price in the near term. Let’s discuss.
3 High-Yield Stocks Wall Street Predicts Will Rally 55% or More
The U.S. equity market has been in correction mode lately on concerns over the Fed’s hawkish stance in fighting decades-high inflation and geopolitical issues. Furthermore, many analysts expect the economy to slip into recession. Therefore, we think it could be wise to bet on high-dividend-yielding stocks Sibanye Stillwater (SBSW), ING Groep (ING), and Fortress Transportation and Infrastructure (FTAI) to generate a steady portfolio income stream. Wall Street analysts expect these stocks to rally more than 55% in price in the coming months. Read on.
Wall Street Trims Their Price Targets but Remains Bullish on These 2 Ancillary Cannabis Stocks
With its rapid legalization across major states, demand for cannabis is expected to soar in the coming years amid new discoveries of its medicinal benefits. While Wall Street analysts have trimmed their price targets for ancillary cannabis stocks GrowGeneration (GRWG) and Innovative Industrial Properties (IIPR), they still expect them to rally by more than 80% in the coming months. So, we think it could be wise to add these stocks to one’s watchlist. Read on.
5 Stocks to Avoid on a Slowdown in E-Commerce Sales
Amid vexing inflation and hawkish federal monetary policy stance, the e-commerce sector suffered a significant earnings decline in its latest quarter. Given the bearish market sentiment, we think it could be wise to now avoid overvalued e-commerce stocks Etsy (ETSY), eBay (EBAY), Shopify (SHOP), Amazon.com (AMZN), and Wayfair (W). Read on.
Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows
Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population. The stocks of quality healthcare companies Bausch Health (BHC), Teleflex (TFX), Abcam (ABCM), and Integra LifeSciences (IART) are currently trading near their 52-week lows, but they are rated Buy in our proprietary rating system. So, let’s discuss.
2 Copper Stocks to Consider Buying on the Dip
With continuing production and supply chain hurdles, the copper shortage has become worldwide. However, demand for copper across several industries continues to be strong. Thus, amid surging copper price estimates, we think it could be wise to bet on the stocks of quality copper companies Southern Copper (SCCO) and Freeport-McMoRan (FCX), which have suffered price dips recently but have solid upside potential. Read on.
3 Top-Quality Tech Stocks Rated 'Strong Buy'
Despite the continuing market correction, the Fed is largely optimistic about a resilient U.S. economy and a rebound in the coming quarters. So, quality tech stocks Playtika (PLTK), Genpact (G), and VMware (VMW) could be solid bets now. They are rated Strong Buys in our proprietary rating system. Read on.
3 High-Yield Dividend Stocks to Buy in May: GlaxoSmithKline, A.P. Moeller-Maersk, and ENI
With the latest federal interest rate hike and the possibility of further monetary policy tightening, market indices have been going haywire. Because volatility is expected to persist, with experts fearing the economy will slip into recession, we think it could be wise to bet on high dividend-yielding stocks GlaxoSmithKline (GSK), A.P. Møller - Mærsk (AMKBY), and Eni (E) to generate a steady income stream. Let’s discuss.